UBS AM’s AngioDynamics ANGO Stock Holding History

UBS AM’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.3K	Hold	1,102	–	–	﹤0.01%	3200
2026 Q1	$12.5K	Buy	1,102 +222	+25%	+$2.41K	﹤0.01%	3258
2025 Q4	$11.3K	Buy	+880	New	+$10.9K	﹤0.01%	2832
2025 Q3	–	Sell	-22,070	Closed	-$219K	–	2286
2025 Q2	$219K	Buy	+22,070	New	+$216K	﹤0.01%	2555
2023 Q4	–	Sell	-43,277	Closed	-$316K	–	2543
2023 Q3	$316K	Sell	43,277 -8,674	-17%	-$72.2K	﹤0.01%	2418
2023 Q2	$537K	Hold	51,951	–	–	﹤0.01%	2291
2023 Q1	$537K	Buy	51,951 +4,011	+8%	+$51.3K	﹤0.01%	2291
2022 Q4	$660K	Buy	47,940 +1,041	+2%	+$14.5K	﹤0.01%	2057
2022 Q3	$960K	Sell	46,899 -5,484	-10%	-$120K	﹤0.01%	1993
2022 Q2	$1.01M	Buy	52,383 +6,311	+14%	+$129K	﹤0.01%	1952
2022 Q1	$992K	Buy	46,072 +2,265	+5%	+$51.4K	﹤0.01%	2148
2021 Q4	$1.21M	Buy	43,807 +4,428	+11%	+$122K	﹤0.01%	2109
2021 Q3	$1.02M	Buy	39,379 +8,674	+28%	+$232K	﹤0.01%	2156
2021 Q2	$833K	Buy	30,705 +77	+0.3%	+$1.88K	﹤0.01%	2313
2021 Q1	$717K	Hold	30,628	–	–	﹤0.01%	2240
2020 Q4	$470K	Hold	30,628	–	–	﹤0.01%	2320
2020 Q3	$369K	Hold	30,628	–	–	﹤0.01%	2255
2020 Q2	$311K	Buy	30,628 +2,992	+11%	+$30.8K	﹤0.01%	2268
2020 Q1	$288K	Sell	27,636 -743	-3%	-$9.33K	﹤0.01%	2170
2019 Q4	$454K	Sell	28,379 -874	-3%	-$13.3K	﹤0.01%	2272
2019 Q3	$539K	Buy	29,253 +7,469	+34%	+$146K	﹤0.01%	2257
2019 Q2	$429K	Buy	21,784 +746	+4%	+$15.2K	﹤0.01%	2278
2019 Q1	$481K	Buy	21,038 +10,040	+91%	+$218K	﹤0.01%	2125
2018 Q4	$221K	Sell	10,998 -9,340	-46%	-$193K	﹤0.01%	2344
2018 Q3	$442K	Hold	20,338	–	–	﹤0.01%	2136
2018 Q2	$452K	Sell	20,338 -2,602	-11%	-$53.2K	﹤0.01%	2139
2018 Q1	$396K	Buy	22,940 +11,942	+109%	+$199K	﹤0.01%	2117
2017 Q4	$183K	Hold	10,998	–	–	﹤0.01%	2338
2017 Q3	$188K	Hold	10,998	–	–	﹤0.01%	2281
2017 Q2	$178K	Hold	10,998	–	–	﹤0.01%	2261
2017 Q1	$191K	Buy	+10,998	New	+$184K	﹤0.01%	2207
2016 Q4	–	Sell	-18,398	Closed	-$323K	–	2504
2016 Q3	$323K	Hold	18,398	–	–	﹤0.01%	2225
2016 Q2	$264K	Hold	18,398	–	–	﹤0.01%	2285
2016 Q1	$226K	Sell	18,398 -1,431	-7%	-$15.8K	﹤0.01%	2372
2015 Q4	$241K	Hold	19,829	–	–	﹤0.01%	2450
2015 Q3	$262K	Hold	19,829	–	–	﹤0.01%	2359
2015 Q2	$325K	Buy	19,829 +3,700	+23%	+$61.4K	﹤0.01%	2317
2015 Q1	$287K	Buy	+16,129	New	+$300K	﹤0.01%	2287
2013 Q4	–	Sell	-10,329	Closed	-$136K	–	2535
2013 Q3	$136K	Hold	10,329	–	–	﹤0.01%	2416
2013 Q2	$117K	Buy	+10,329	New	+$110K	﹤0.01%	2374

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's ANGO Position: Q2 2026 in Review

UBS AM held its AngioDynamics (ANGO) position steady in Q2 2026 at 1,102 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

UBS AM first reported a position in ANGO in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.21M in Q4 2021. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

UBS AM held 1,102 shares of AngioDynamics worth $14.3K as of Q2 2026.
UBS AM left its AngioDynamics share count unchanged in Q2 2026.
AngioDynamics made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3200 holding.
UBS AM first reported a position in AngioDynamics in Q2 2013 and has held it in 40 quarters since.
UBS AM's AngioDynamics position peaked at $1.21M in Q4 2021.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.